‘Nice bites diabetes’

COVID-19 Medicines Optimisation (15)
- COVID-19 Medicines Optimisation resources (1)
- COVID-19 Specialty Summaries (14)
Care Setting (27)
- Care homes (5)
- Care of the elderly (1)
- Community Health Services (5)
- Critical care (2)
- Dentistry (2)
- Health and Justice (5)
- Paediatrics (1)
- Palliative and End of Life Care (4)
- Primary Care and PCNs (14)
- Transfer of care (2)
- Trusts (6)
Events (5)
- Past Events (5)
Guidance (71)
- Adherence (1)
- Administering (8)
- Advanced therapy medicinal products (2)
- Adverse effects (3)
- Cautions and contraindications (4)
- Complementary medicines (3)
- Dosing (2)
- Formulation (5)
- Implementation (9)
- Interactions (3)
- Legislation (1)
- Medicines Safety (17)
- Patient Group Directions (27)
- Policy, Commissioning and Managerial (4)
- Polypharmacy (2)
- Porphyria (1)
- Preparing (2)
- Prescribing (1)
- Regulatory (4)
- Safety in Breastfeeding (2)
- Safety in Pregnancy (15)
- Supply (4)
- Swallowing difficulties (3)
- Switching (3)
- Unlicensed medicines (1)
Medicine (25)
- Acrivastine (1)
- Adrenaline (1)
- Agomelatine (1)
- Alendronic acid (1)
- Amitriptyline (1)
- Atorvastatin (2)
- Atovaquone (1)
- Beclometasone (1)
- Beclometasone + Formoterol (1)
- Benzylpenicillin (1)
- Betamethasone (1)
- Budesonide (1)
- Budesonide + Formoterol (1)
- Buprenorphine (1)
- Carbamazepine (1)
- Carbidopa + Levodopa + Entacapone (1)
- Cetirizine (1)
- Chloroquine (1)
- Chlorphenamine (1)
- Cholesterol + Simvastatin (1)
- Ciclosporin (1)
- Citalopram (2)
- Codeine (2)
- Dalteparin (1)
- Desloratadine (1)
- Dihydrocodeine (2)
- Diltiazem (1)
- Doxazosin (1)
- Doxepin (1)
- Doxycycline (1)
- Duloxetine (1)
- Enoxaparin (1)
- Escitalopram (1)
- Fentanyl (1)
- Fexofenadine (1)
- Fidaxomicin (1)
- Fluoxetine (2)
- Fluticasone (1)
- Fluticasone + Formoterol (1)
- Fluticasone + Salmeterol (1)
- Fluvastatin (2)
- Fluvoxamine (2)
- Gabapentin (1)
- Gadobutrol (1)
- Gadoteric acid (1)
- Gadoteridol (1)
- Hydromorphone (2)
- Hydroxychloroquine (1)
- Hydroxyzine (1)
- Ibandronic acid (1)
- Imipramine (1)
- Insulin aspart (1)
- Insulin detemir (1)
- Insulin glargine (2)
- Insulin glulisine (1)
- Insulin human (1)
- Insulin isophane human (1)
- Insulin lispro (1)
- Iodixanol (1)
- Iohexol (1)
- Iomeprol (1)
- Iopamidol (1)
- Ioversol (1)
- Isocarboxazid (1)
- Levocetirizine (1)
- Levodopa (1)
- Levodopa + Carbidopa + Entacapone (1)
- Levothyroxine (1)
- Lithium (1)
- Lithium carbonate (1)
- Lofepramine (1)
- Loratadine (1)
- Lovastatin (1)
- Mesalazine (2)
- Metformin (1)
- Methotrexate (1)
- Methylphenidate (2)
- Mianserin (1)
- Miconazole (1)
- Mirtazapine (1)
- Moclobemide (1)
- Morphine (3)
- Mycophenolate mofetil (1)
- Naloxone (1)
- Nifedipine (1)
- Nortriptyline (1)
- Nystatin (1)
- Oxycodone (3)
- Paroxetine (2)
- Phenelzine (1)
- Phenobarbital (1)
- Phenytoin (1)
- Potassium permanganate (1)
- Pravastatin (2)
- Pregabalin (1)
- Primidone (1)
- Proguanil (1)
- Proguanil + Atovaquone (1)
- Promethazine hydrochloride (1)
- Promethazine teoclate (1)
- Reboxetine (1)
- Risedronate sodium (1)
- Rosuvastatin (2)
- Selegiline (1)
- Sertraline (2)
- Simvastatin (2)
- Tacrolimus (1)
- Tapentadol (2)
- Tinzaparin (1)
- Tiotropium (1)
- Tramadol (3)
- Tranylcypromine (1)
- Trimipramine (1)
- Vancomycin (1)
- Venlafaxine (2)
- Vortioxetine (1)
- Warfarin (1)
Planning (9)
- New Medicines (3)
  - CCG commissioned new medicines (1)
  - NHS England commissioned new medicines (1)
- Patient Group Direction Planning (6)
Publications (14)
- RMOC recommendations and resources (1)
- Research and audits (4)
- Summary advice (3)
- Templates (5)
Specialty (51)
- Allergy and immunology (5)
- Anaesthesia and pain (2)
- Cancers (2)
- Cardiovascular system disorders (4)
- Diabetes (3)
- Endocrine system disorders (4)
- Gastrointestinal disorders (6)
- Haematological disorders (5)
- Infection and infectious diseases (3)
- Mental health and illness (10)
- Musculo-skeletal disorders (1)
- Neurological disorders (4)
- Nutritional and metabolic disorders (1)
- Obstetrics and gynaecology (1)
- Public Health (1)
- Renal and urologic disorders (2)
- Reproductive health (1)
- Respiratory disorders (8)
- Skin disorders (2)
- Surgery (2)
- Transplantation (1)
- Travel Medicine (1)
- Wounds and injuries (1)
Training and Development (6)
- Training and Development materials (6)

Diabetes: treatment during pregnancy

6 January 2022Signposting evidence-based information on the treatment of diabetes in pregnancy

Primary Care Discussions: Focus on Diabetes

31 March 202231 March: Challenging discussions on Diabetes - an 'On the Couch' discussion between specialist pharmacists

NICE: COVID-19 rapid guideline on severe asthma

3 April 2020NICE NG 166 aims to maximise safety of patients with severe asthma during the COVID-19 pandemic while

NICE: COVID-19 rapid guideline cystic fibrosis

9 April 2020NICE NG 170 aims to maximise safety of patients with cystic fibrosis during the pandemic while protecting

NICE COVID-19 rapid guideline: interstitial lung disease

5 May 2020NICE NG 177 aims to maximise safety of patients with this condition during the pandemic while protecting

NICE Rapid Guideline: Managing COVID-19

17 April 2020NICE NG191 covers management of COVID-19 for children, young people and adults in all care settings.

NICE Rapid Guideline: dermatological conditions treated with drugs affecting the immune response

9 April 2020NICE NG169 covers safety of children and adults who have dermatological conditions during COVID-19.

NICE: COVID-19 rapid guideline community-based care of patients with chronic obstructive pulmonary disease (COPD)

9 April 2020NICE NG 168 aims to maximise safety of patients with COPD during the COVID-19 pandemic while protecting

UKMIQA_porphyria-and-travel · 43.55 KB

20 December 2019At destination Take measures to avoid mosquito bites, e.g. use nets and repellent, clothing that covers

QA259_4_Antimalarials_Final.doc · 121.50 KB

5 September 2014repellents, covering up with clothing from dusk, and the use of impregnated bed nets will help prevent bites

SPS - Specialist Pharmacy Service

NHS